Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
The DEA’s potential introduction of a telehealth-controlled substance registry is lauded by the American Telemedicine Association (ATA). The DEA’s upcoming listening sessions aim to explore the feasibility of remote prescribing of essential controlled substances…
Continue Reading
The American Telemedicine Association released a statement on Friday saying that it applauds the Drug Enforcement Agency for posting a meeting notice on Friday that indicates that it is “openly considering” a special registration that would…
Continue Reading
By Mark Melchionna
June 29, 2023 – Amid the ongoing concerns surrounding virtual prescribing allowances for attention-deficit hyperactivity disorder (ADHD) medications, a new study found that health systems provide prescriptions for this condition and anxiety at…
Continue Reading
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s…
Continue Reading
The U.S. DEA and HHS have extended telemedicine flexibilities for controlled medication prescriptions, initially granted during the COVID-19 pandemic. The extension, lasting six months until November 2023, allows virtual prescribing and promises a grace…
Continue Reading
This past week, the U.S. Drug Enforcement Agency and the U.S. Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public…
Continue Reading
The DEA and SAMHSA have extended telehealth prescribing flexibilities for controlled substances through November 11, 2024, following a temporary rule. The move comes after several healthcare organizations, including the AHA, requested continued telehealth prescribing…
Continue Reading
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading
By Mark Melchionna
May 08, 2023 – Led by Sen. Edward J. Markey (D-Mass.), a group of US senators have urged the Drug Enforcement Agency (DEA) to permanently establish telehealth flexibilities in prescribing buprenorphine for opioid…
Continue Reading
